01.02.13
German company Symrise AG and the probiotics company Probi AB, Lund, Sweden, have signed a joint research and developmentagreement.In response to the growing need for turnkey product solutions with proven healthbenefits, both companies have announced plans to collaborate oninnovative projects, initially focusing on oral health applications. Symrise AG currently holds a 14.97% minority share of Probi and may increasethis stake in the future.
Symrise has expertise in the research, development and manufacturing of food,beverages, cosmetics and pharmaceutical products and sees increasingpotential in the health benefits of probiotics. The company combines the abilityand the network to perform efficacy screening with the necessary know-how ofapplying active ingredients. Further, Symrise holds a globally leading positionin the area of oral care.
Probi’s experience is in the research,development and manufacturing of probiotics, and sells gut and immune health probiotics available on the world market.
Symrise has expertise in the research, development and manufacturing of food,beverages, cosmetics and pharmaceutical products and sees increasingpotential in the health benefits of probiotics. The company combines the abilityand the network to perform efficacy screening with the necessary know-how ofapplying active ingredients. Further, Symrise holds a globally leading positionin the area of oral care.
Probi’s experience is in the research,development and manufacturing of probiotics, and sells gut and immune health probiotics available on the world market.
